3 best performing ASX shares in week 10, 7 March 2022

Marc Kennis Marc Kennis, March 14, 2022

Best performing ASX shares

This week’s best performing ASX shares are Terramin Australia (ASX:TZN), up 87%, Toro Energy (ASX:TOE), up 56.3%, and Lotus Resources (ASX:LOT), up 42.3%.

 

GET A 30-DAY FREE TRIAL TO STOCKS DOWN UNDER

 
1. Terramin Australia (ASX:TZN)

Industry: Basic Materials

Terramin Australia Limited (ASX:TZN) engages in the exploration, evaluation and development of base and precious metal projects in Australia and overseas. Terramin has a clear focus on growing a production pipeline of base and precious metal projects close to infrastructure and with low capital and operating costs. Consistent with this focus, the Group holds a number of highly prospective moneral deposits and exploration tenements across South Australian and Algerian locations.

Market Cap: $91m

12 month high / low: $0.019 – $0.052

 

Terramin

 

 

2. Toro Energy (ASX:TOE)

Industry: Energy

Toro Energy Limited (TOE) is an ASX listed uranium development and exploration company with projects in WA. Current focus of the company is on advancement and development of Wiluna Uranium Project and initiate exploration of Yandal gold project.

Market Cap: $97M

12 month high / low: $0.012 – $0.058

 

Toro Energy

 

 

3. Lotus Resources (ASX:LOT)

Industry: Energy

Lotus Resources Limited (ASX:LOT, formerly Hylea Metals Limited) is a mineral exploration company with projects located in New South Wales and Western Australia. The projects encompass uranium, cobalt, platinum, nickel and base metals.

Market Cap: $368

12 month high / low: $0.12 – $0.38

 

Lotus Resources

 

 

Learn more about ASX-listed stocks with
Stocks Down Under!

 

Subscribe to Stocks Down Under today!

 

GET A 30-DAY FREE TRIAL

 

No credit card needed and the trial expires automatically.

 

 

Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

Orthocell

Orthocell (ASX:OCC): All systems go for a US market roll out of its flagship Remplir nerve repair product

Orthocell (ASX:OCC) is the latest ASX biotech to obtain FDA approval. Its nerve repair product Remplir was already approved in…

how tariffs impact the stock market

Here’s how tariffs impact the stock market and its investors

Many would be wondering how tariffs impact the stock market and its investors. On ‘Liberation Day‘, the returned President Trump…

oldest companies on the ASX

What are the oldest companies on the ASX? Here are 5 of them and the secrets to their success!

In this article, we look at 5 of the oldest companies on the ASX. Now, we are not claiming these…